A New Wonder Cancer Drug

Gleevec is an inelastic crabmeat drug which created a monopoly in the pharmaceutic crab lo manipulation drug market in the recent years. Since Gleevec is a life saving drug and it has no competition, it does not impediment affected by most of the economic conditions. Gleevecs closest fray is still in development phase and there is no guarantee that it will be completed or empower by the Federal Drug Administration (FDA) therefore Gleevec has no fear of a competitor coming into the pharmaceutical malignant neoplastic disease drug market in the near future. Continuous studies are showing compromising affects of Gleevec on heart diseases besides leukemia and if O.K. by the FDA in the future Gleevec can be use to cure heart diseases which may expands Gleevecs use and pull its deserving down due to increase of demand. Gleevec is a new type of cancer drug; the first of its kind developed to hand cancer by turning off an enzyme that types cells to become cancerous and mu ltiply. The U.S. Food and Drug Administration approved Gleevec (imatinib mesylate, or STI-571), in May 2001 for treating patients with three stages of chronic myelogenous leukemia (CML). Gleevec was approved under the U.S. governments strip drug program, which provides financial incentives for the development of drugs to treat rare diseases.

gift was based on clinical studies that demonstrated the drugs effectiveness in 90% of the patients studied. CML is a personal credit line cancer in which there are too many insurgent neat ancestry cells. These cells, which dont work correctly, crowd out the standard white blood cells. This clogs up the bloodstream and leaves the body with! no defense against infections. The cause of CML is a gene on a chromosome called the Philadelphia chromosome. The gene makes a poisonous protein that causes cancer in white blood cells. Gleevec works... If you unavoidableness to get a full essay, order it on our website: BestEssayCheap.com

If you want to get a full essay, visit our page: cheap essay